JPMORGAN CHASE & CO - VERTEX PHARMACEUTICALS INC ownership

VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F950. A total of 9 filers reported holding VERTEX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of VERTEX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$17,143,582
+119.4%
49,300
+122.1%
0.00%
+100.0%
Q2 2023$7,812,402
+6.9%
22,200
-4.3%
0.00%0.0%
Q1 2023$7,310,000
+170934.2%
23,200
+56.8%
0.00%0.0%
Q4 2022$4,274
-99.8%
14,800
+105.6%
0.00%
Q3 2022$2,085,000
+15.6%
7,200
+12.5%
0.00%
Q2 2022$1,803,000
+3367.3%
6,400
+3100.0%
0.00%
Q1 2022$52,000
-99.4%
200
-99.5%
0.00%
-100.0%
Q4 2021$8,586,000
+21.1%
39,1000.0%0.00%0.0%
Q3 2021$7,092,000
-10.0%
39,1000.0%0.00%0.0%
Q2 2021$7,884,000
-83.6%
39,100
-82.5%
0.00%
-83.3%
Q1 2021$48,114,000
+374.6%
223,900
+383.6%
0.01%
+200.0%
Q4 2019$10,137,000
+127.5%
46,300
+76.0%
0.00%
+100.0%
Q3 2019$4,456,000
-5.1%
26,3000.0%0.00%0.0%
Q2 2019$4,697,000
-58.9%
26,300
-57.6%
0.00%
-50.0%
Q1 2019$11,423,000
+76.3%
62,100
+58.8%
0.00%
+100.0%
Q4 2018$6,479,000
-12.7%
39,100
+1.6%
0.00%0.0%
Q3 2018$7,420,000
-21.6%
38,500
-30.9%
0.00%
-50.0%
Q2 2018$9,467,000
-12.5%
55,700
-16.1%
0.00%0.0%
Q1 2018$10,822,000
+262.9%
66,400
+233.7%
0.00%
+100.0%
Q4 2017$2,982,000
-90.4%
19,900
-90.5%
0.00%
-85.7%
Q3 2017$31,196,000
+528.4%
208,500
+359.3%
0.01%
+600.0%
Q1 2017$4,964,00045,4000.00%
Other shareholders
VERTEX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 224,200$63,177,0000.10%
Twin Tree Management, LP 54,800$15,442,0000.02%
JANE STREET GROUP, LLC 161,500$45,509,0000.02%
SIMPLEX TRADING, LLC 54,100$15,244,0000.02%
SG Americas Securities, LLC 20,000$170,0000.00%
JPMORGAN CHASE & CO 6,400$1,803,0000.00%
Allianz Asset Management GmbH 500$141,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of VERTEX PHARMACEUTICALS INC shareholders